Cbtaz 1.125gm Injection
Marketer
Chandra Bhagat Pharma Pvt Ltd
Salt Composition
Cefepime (1000mg) + Tazobactum (125mg)
Overview Cbtaz 1.125gm Injection
Ceftriaxone 1.125g injection combines two antibiotics to combat diverse bacterial infections. Its mechanism involves hindering microbial proliferation. Administration must be solely by a healthcare provider. Strictly adhere to the prescribed dosage schedule; complete the entire course, regardless of symptom improvement. Typical side effects include nausea, vomiting, diarrhea, and skin rashes. Injection site reactions (redness, swelling, pain) may occur but usually resolve. Severe or persistent side effects necessitate immediate medical attention. Seek immediate medical help for allergic reactions (rashes, itching, swelling, breathing difficulties). Inform your doctor about all current medications, especially if pregnant or breastfeeding, before commencing treatment. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, refrain from driving if drowsiness or dizziness occurs.
Primary Ingredients of Cbtaz 1.125gm Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Cbtaz 1.125gm Injection
Infections caused by bacteria
Major Benefits of Cbtaz 1.125gm Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Cbtaz 1.125gm Injection:
- Diarrhea
- Increased white blood cell count (eosinophils)
- Injection site phlebitis
- Skin rash
- Increased liver enzymes
- Positive Coombs test
How to use Cbtaz 1.125gm Injection:
This medication will be administered by your physician or their qualified staff; self-medication is strongly discouraged.
How Cbtaz 1.125gm Injection works:
Cbtaz 1.125gm Injection unites Cefepime, an antibiotic, with Tazobactum, a beta-lactamase inhibitor. Cefepime's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Tazobactum counteracts bacterial enzymes that would otherwise neutralize Cefepime's effect. This synergistic action broadens Cefepime's efficacy and overcomes bacterial resistance.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Cbtaz 1.125gm Injection alongside alcohol. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The injectable medication Cbtaz (1.125 gm) is typically deemed safe for use during gestation. Preclinical trials using animals revealed minimal or no negative consequences for fetal development; nonetheless, research involving human subjects is currently scant.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Cbtaz (1.125 gm) is considered safe for use while breastfeeding. Research in humans indicates minimal drug transfer into breast milk, posing no identified risk to the infant.
DrivingUNSAFE
Following administration of a 1.125-gram Cbtaz injection, temporary blurred vision may occur. Refrain from driving until visual acuity returns to normal.
KidneyCAUTION
Ceftazidime 1.125-gram injections require careful administration for individuals with impaired renal function. Dosage modifications may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of a 1.125-gram Cbtaz injection in individuals with hepatic impairment is likely safe. Available evidence indicates dose modification may be unnecessary; however, physician consultation is advised.
What if you forget to take Cbtaz 1.125gm Injection :
Should you forget a scheduled Cbtaz 1.125gm Injection, seek medical advice.
Facts to Know About Cbtaz 1.125gm Injection
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently